Enzolytics Inc (ENZC)

[anarmyofme]

Summary:


Enzolytics, Inc. owns licensing rights of the Irreversible Pepsin Fraction peptide molecule for the treatment of HIV/AIDS.

The company's treatment appears to be different from other treatments. Enzolytics Inc. claims to be offering a product with zero toxicity issues, minor side effects, and cost savings.

According to their website, they have tested 31 patients. Besides, they are about to acquire a new laboratory, which will most likely be operational in June 2021.

Enzolytics Inc. targets a market that could be close to $37 billion in 2027. That's a large market size. However, numerous companies are already selling HIV drugs. The competition in the market is significant.

Enzolytics Inc. may need to test hundreds of patients. The process will also take a lot of time and financial resources. Shareholders need to understand well that they may have to wait many years until Enzolytics Inc. can report sales.